Company / Operating Cash Flow
Oric Pharmaceuticals, Inc. Operating Cash Flow History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$111.0M
FY2025
5-year range
-$112.7M / -$59.5M
FY2021-FY2025
Trend
+1.5%
vs FY2024
Sector context
#127 of 216
Health Care
What the data says
At -$111M, Oric Pharmaceuticals, Inc.'s operating cash flow ranks #127 of 216 in the Health Care sector. Operating Cash Flow returned to growth in FY2025 after 6 years of decline, reaching -$111M.
Based on SEC 10-K filings.
-$111M in FY2025.
Declined from -$86M to -$111M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#127 of 216 in Health CareTop 59% of 216This company -$111.0M Sector average $658.7M
▼
-116.8% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow increased 1.5% year-over-year.
- Ranks #127 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2018.
- Lowest operating cash flow in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$111.0M | +1.5% |
| FY2024 | -$112.7M | -31.5% |
| FY2023 | -$85.7M | -14.0% |
| FY2022 | -$75.1M | -26.2% |
| FY2021 | -$59.5M | -31.5% |
| FY2020 | -$45.3M | -92.4% |
| FY2019 | -$23.5M | -13.8% |
| FY2018 | -$20.7M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026